Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion
Source abstract
Abstract
The long-term safety and immunological effects of bovine poly-[haemoglobin-catalase-superoxide dismutase-carbonic anhydrase] in rats are studied by four-weekly 5% blood volume top-loading infusions followed by 30% blood volume exchange transfusion. There is no significant difference in growth, biochemistry and blood pressure between the control group receiving lactated ringer solution and those receiving the bovine poly-[haemoglobin-catalase-superoxide dismutase-carbonic anhydrase]. There is no significant change in mean arterial pressures (MAP) before and after each weekly top-loading infusion. After both the four weekly top-loading and the 30% exchange transfusions, the following safety and immune response evaluations are carried out. These include general studies on Ouchterlony double diffusion, total IgG and IgM, and complement activation. This is followed by quantitative measurements of specific antibodies against each of the following bovine components: Hb, CAT, SOD and CA in bovine poly-[haemoglobin-catalase-superoxide dismutase-carbonic anhydrase]. After the four weekly top-loading, each rat received a challenge of 30% blood volume exchange transfusion. The MAP, histamine and tryptase levels are tested before and after the 30% exchange transfusion. There are no anaphylactic reactions as shown by the MAP or histamine and tryptase. The results showed no safety problem nor adverse immune responses. All the rats survived when followed for one week after the 30% exchange transfusion.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hemoglobin structure and function · Erythropoietin and Anemia Treatment · Erythrocyte Function and Pathophysiology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Artficial Cells and Organs Research Centre, Departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, QC, Canada
Funding
Canadian Blood Service · Canadian Institutes of Health Research
References (42)
Show source-provided references
1. 10.1142/639510.1142/6395 ↗
2. 10.1016/j.ccc.2008.12.00610.1016/j.ccc.2008.12.006 ↗
3. 10.3109/10731199.2012.66240810.3109/10731199.2012.662408 ↗
4. 10.1080/21691401.2017.129367610.1080/21691401.2017.1293676 ↗
5. Kim HW · 2014
6. 10.1111/trf.1372610.1111/trf.13726 ↗
7. 10.1111/trf.1392310.1111/trf.13923 ↗
8. 10.1126/science.146.3643.52410.1126/science.146.3643.524 ↗
9. 10.1016/S0006-291X(71)80260-710.1016/S0006-291X(71)80260-7 ↗
10. 10.1097/TA.0b013e318173a93f10.1097/TA.0b013e318173a93f ↗
11. 10.1016/j.jamcollsurg.2008.09.02310.1016/j.jamcollsurg.2008.09.023 ↗
12. Weiskopf RB · Transfusion · 2013 · 53 · 232710.1111/trf.12018 ↗
13. 10.1038/nbt0798-66710.1038/nbt0798-667 ↗
14. 10.1081/BIO-12000272510.1081/BIO-120002725 ↗
15. 10.1089/ars.2004.6.94110.1089/ars.2004.6.941 ↗
16. 10.1517/14712598.7.5.66510.1517/14712598.7.5.665 ↗
17. 10.1016/j.freeradbiomed.2004.04.00810.1016/j.freeradbiomed.2004.04.008 ↗
18. Ma L
19. 10.1097/00005373-200112000-0002010.1097/00005373-200112000-00020 ↗
20. 10.3109/10731199.2011.58105210.3109/10731199.2011.581052 ↗
21. 10.3109/21691401.2014.96455410.3109/21691401.2014.964554 ↗
22. 10.3109/10731199.2013.74529110.3109/10731199.2013.745291 ↗
23. 10.3109/21691401.2015.111087110.3109/21691401.2015.1110871 ↗
24. 10.3109/21691401.2015.103547910.3109/21691401.2015.1035479 ↗
25. 10.3109/21691401.2015.104755710.3109/21691401.2015.1047557 ↗
26. 10.1007/978-1-60327-259-9_13510.1007/978-1-60327-259-9_135 ↗
27. 10.1002/pro.220010.1002/pro.2200 ↗
28. Ning J · Biomat Artif Cells Artif Organs · 1987 · 15 · 380
29. 10.3109/1073119900911730310.3109/10731199009117303 ↗
30. Chang TMS · 1997
31. 10.1016/j.rmed.2011.09.00710.1016/j.rmed.2011.09.007 ↗
32. 10.1159/00005940410.1159/000059404 ↗
33. 10.1080/21691401.2016.124179710.1080/21691401.2016.1241797 ↗
34. Arthurs G · Crit Care Pain. 2005; · 5 · 207
35. 10.1152/physrev.2000.80.2.68110.1152/physrev.2000.80.2.681 ↗
36. 10.1080/21691401.2016.119122910.1080/21691401.2016.1191229 ↗
37. 10.1080/21691401.2016.122866510.1080/21691401.2016.1228665 ↗
38. 10.1080/21691401.2016.124179510.1080/21691401.2016.1241795 ↗
39. 10.1080/21691401.2016.126364010.1080/21691401.2016.1263640 ↗
40. 10.1080/21691401.2016.118572810.1080/21691401.2016.1185728 ↗
41. 10.1080/21691401.2017.128286910.1080/21691401.2017.1282869 ↗
42. 10.3109/1073119100363423210.3109/10731191003634232 ↗